May contain inaccuracies · Check primary sources · Not medical advice · Not for human or animal use

Non-peptide

Tamoxifen

Also known as

Nolvadex · Nolva · tamoxifen citrate · tamoxifen 20 mg

Community talk. May contain inaccuracies. Not medical advice. Not a protocol. Not for human or animal use.

What it is

IdentityAn oral selective estrogen-receptor modulator, or SERM, called Nolvadex or Nolva. Bodybuilding discussion concerns breast-lump symptoms and post-cycle attempts to recover hormone function.
Different from an AITamoxifen changes estrogen signaling at receptors; an aromatase inhibitor reduces estrogen production. A smaller breast lump does not show circulating estrogen has fallen.
Notes

Tamoxifen, usually called Nolvadex or Nolva, is an oral selective estrogen-receptor modulator (SERM). Bodybuilding communities discuss it for breast-lump concerns and post-cycle therapy (PCT), meaning attempts to recover hormone function after suppressive drugs. Reports include smaller lumps, feeling unchanged and difficult mood or concentration problems; those outcomes are not interchangeable.

Usually tablets, with quantities expressed in milligrams. The original discussions name 10 mg and 20 mg tablets, swallowed orally, with no reconstitution. Oncology treatment is a separate medical setting; its purpose and duration do not validate a bodybuilding course.

A receptor drug, not an estrogen-production blocker. Tamoxifen changes estrogen signaling in particular tissues. An aromatase inhibitor (AI), such as anastrozole, reduces estrogen production. Calling both an estrogen blocker hides a practical difference: a breast-lump response does not show that circulating estrogen has fallen. DailyMed Tamoxifen Citrate oral-tablet prescribing label (Official context · Accessed 2026-09-30)

Source context — DailyMed Tamoxifen Citrate oral-tablet prescribing label: A-S Medication Solutions repackaged label, source NDC0591-2472. Medical breast-cancer contexts, not a PCT trial or a short-course male risk estimate. Rat mechanism text not promoted to human efficacy; no measured benefit duration.

What people notice

Smaller breast lumpsSome describe visible or touchable reduction, sometimes incomplete. One still had a lump after three weeks at 40 mg/day; reports do not guarantee that a lump disappears.
Recovery can feel unchangedPCT users seek better energy and libido, but feeling better does not establish lasting hormone recovery. One person felt unchanged at day six; another reported lower free testosterone and LH after four weeks.
Notes

A smaller or less troubling breast lump. Several gynecomastia accounts describe visible or touchable reduction, sometimes incomplete. One commenter still had a lump after three weeks at 40 mg/day. The recurring interest in newer tissue is community discussion, not a guarantee that any lump will disappear. Positive Experiences on Tamoxifen or Raloxifene, including adverse follow-ups (Community discussion · Accessed 2026-09-30)

Feeling normal again after a cycle. PCT users seek better energy, libido and hormone results. The original record also preserves the competing explanation that a bad week may be the post-cycle crash itself. Feeling better cannot establish durable hormone recovery. Changed values in free testosterone and LH after pct cycle with Nolvadex (Personal report · Accessed 2026-09-30)

No noticeable feeling is also a report. The day-six commenter took 20 mg before bed and noticed no change or side effects, despite another reply warning against night dosing. Clinic, forum and unverified-product experiences are different contexts; a seller name or favorable feeling does not verify contents. What to expect from Nolvadex as a PCT? (Community discussion · Accessed 2026-09-30)

Hormone numbers do not always follow the expected story. After ostarine and four weeks of tamoxifen, one poster reported lower free testosterone and lower luteinizing hormone, a signal that stimulates testosterone production. Replies blamed fake product, but that was unverified. Supplements, test timing and changing hormone-binding proteins further limit interpretation. Changed values in free testosterone and LH after pct cycle with Nolvadex (Personal report · Accessed 2026-09-30)

Source context — Positive Experiences on Tamoxifen or Raloxifene, including adverse follow-ups: Self-selected positive-story prompt; OP's later adverse reports are the same person. Subjective reduction and reported radiology not independently verified. Planned 40 mg increase at line 336 is not confirmed completed use. Hidden/deleted replies unavailable; commercial purchase suggestions excluded.

Source context — Changed values in free testosterone and LH after pct cycle with Nolvadex: Self-reported laboratory values, no independently inspected reports or controlled timing. Prior ostarine plus boron/ZMA; counterfeit assertions unverified. Duplicate r/sarmssourcetalk yqp5bb is the same account and is not counted independently.

Source context — What to expect from Nolvadex as a PCT?: OP proposes a course, not a completed outcome. No biochemical follow-up for the day-six commenter; source/purchase language omitted. Other replies give unsupported safety assurances and causal claims not adopted.

Doses people talk about

PCT discussionThe older copied band is 20–40 mg/day orally. A separate post planned 20 mg daily for two weeks, then 10 mg daily for two weeks; that was a proposed course, without a completed result.
Breast-lump discussion10–20 mg/day appears, including one author who used 20 mg nightly and later 10 mg daily. A different person reported partial reduction at 40 mg/day for three weeks, without establishing a safe ceiling.
Notes

PCT: 20–40 mg/day in the original kit discussion; lower amounts also appear. A reopened Reddit post planned 20 mg daily for two weeks followed by 10 mg daily for two weeks. That was a proposed four-week course, not a completed success report. The older 20–40 mg band remains a separate community pattern. What to expect from Nolvadex as a PCT? (Community discussion · Accessed 2026-09-30)

Usually tablets, with quantities expressed in milligrams. The original discussions name 10 mg and 20 mg tablets, swallowed orally, with no reconstitution. Oncology treatment is a separate medical setting; its purpose and duration do not validate a bodybuilding course.

Gynecomastia: 10–20 mg/day, with distinct higher reports. One author reported 20 mg each night and later 10 mg daily. A different commenter described 40 mg/day for three weeks with partial reduction. These accounts do not establish a safe ceiling or show that more gives a better result. My gyno experience: raloxifene did not work; tamoxifen switch and follow-up (Personal report · Accessed 2026-09-30) · Positive Experiences on Tamoxifen or Raloxifene, including adverse follow-ups (Community discussion · Accessed 2026-09-30)

Source context — What to expect from Nolvadex as a PCT?: OP proposes a course, not a completed outcome. No biochemical follow-up for the day-six commenter; source/purchase language omitted. Other replies give unsupported safety assurances and causal claims not adopted.

Source context — My gyno experience: raloxifene did not work; tamoxifen switch and follow-up: One account including follow-ups, not independent corroboration. Subjective tissue change, simultaneous antidepressant withdrawal; later follow-ups have relative timestamps only.

Source context — Positive Experiences on Tamoxifen or Raloxifene, including adverse follow-ups: Self-selected positive-story prompt; OP's later adverse reports are the same person. Subjective reduction and reported radiology not independently verified. Planned 40 mg increase at line 336 is not confirmed completed use. Hidden/deleted replies unavailable; commercial purchase suggestions excluded.

Half-life, onset & duration

Felt onsetOne breast-lump account describes almost overnight reduction. A PCT user felt unchanged on day six at 20 mg/day; these different outcomes do not establish a hormone-recovery onset.
Felt durationNo reliable one-dose benefit window is established. Different breast-lump accounts describe no regrowth one month off, or return after stopping; one author reported fog continuing for a month after quitting.
Half-lifeThe human oral-tablet label gives about 5–7 days for tamoxifen and around 14 days for N-desmethyl tamoxifen, a breakdown product. These are separate from felt effects or an on/off schedule.
Notes

Breast changes can be reported within days; PCT can feel unchanged initially. The medication-switch author described almost overnight reduction. Another PCT commenter felt no different on day six at 20 mg/day. These are different endpoints, and neither supplies a predictable onset for hormone recovery. My gyno experience: raloxifene did not work; tamoxifen switch and follow-up (Personal report · Accessed 2026-09-30) · What to expect from Nolvadex as a PCT? (Community discussion · Accessed 2026-09-30)

No reliable single-dose benefit window. These accounts describe repeated use. One author reported no regrowth one month after stopping; another described breast tissue returning after a months-long course and less effect on retry. The positive thread's author reported brain fog continuing for a month after quitting. My gyno experience: raloxifene did not work; tamoxifen switch and follow-up (Personal report · Accessed 2026-09-30) · Positive Experiences on Tamoxifen or Raloxifene, including adverse follow-ups (Community discussion · Accessed 2026-09-30)

Label values keep their medical origin. The oral-tablet label gives a terminal half-life of about 5–7 days for tamoxifen and approximately 14 days for N-desmethyl tamoxifen, a breakdown product. These are human pharmacology values, not user-measured benefit durations or PCT schedules. DailyMed Tamoxifen Citrate oral-tablet prescribing label (Official context · Accessed 2026-09-30)

Source context — My gyno experience: raloxifene did not work; tamoxifen switch and follow-up: One account including follow-ups, not independent corroboration. Subjective tissue change, simultaneous antidepressant withdrawal; later follow-ups have relative timestamps only.

Source context — What to expect from Nolvadex as a PCT?: OP proposes a course, not a completed outcome. No biochemical follow-up for the day-six commenter; source/purchase language omitted. Other replies give unsupported safety assurances and causal claims not adopted.

Source context — Positive Experiences on Tamoxifen or Raloxifene, including adverse follow-ups: Self-selected positive-story prompt; OP's later adverse reports are the same person. Subjective reduction and reported radiology not independently verified. Planned 40 mg increase at line 336 is not confirmed completed use. Hidden/deleted replies unavailable; commercial purchase suggestions excluded.

Source context — DailyMed Tamoxifen Citrate oral-tablet prescribing label: A-S Medication Solutions repackaged label, source NDC0591-2472. Medical breast-cancer contexts, not a PCT trial or a short-course male risk estimate. Rat mechanism text not promoted to human efficacy; no measured benefit duration.

Cycles people discuss

Purpose changes the courseA four-week PCT proposal differs from a breast-lump author who later reported two months at 20 mg and one month at 10 mg. No supported repeat-cycle or time-off rule emerges.
Notes

Four-week PCT discussions are distinct from longer breast-lump accounts. The inspected PCT question proposed four weeks. The switch author later reported two months at 20 mg followed by one month at 10 mg. The original record frames PCT as weeks, not indefinite AI use. No supported repeat-cycle or time-off rule emerges here. What to expect from Nolvadex as a PCT? (Community discussion · Accessed 2026-09-30) · My gyno experience: raloxifene did not work; tamoxifen switch and follow-up (Personal report · Accessed 2026-09-30)

Source context — What to expect from Nolvadex as a PCT?: OP proposes a course, not a completed outcome. No biochemical follow-up for the day-six commenter; source/purchase language omitted. Other replies give unsupported safety assurances and causal claims not adopted.

Source context — My gyno experience: raloxifene did not work; tamoxifen switch and follow-up: One account including follow-ups, not independent corroboration. Subjective tissue change, simultaneous antidepressant withdrawal; later follow-ups have relative timestamps only.

Stacks

Clomiphene combinationsClassic PCT discussion includes adding Clomid. Users disagree: one described no side effects with solo Nolva, while another linked headaches to the combination. The reports do not rank the options.
Heavy AI useThe original record preserves crash concerns with heavy aromatase-inhibitor use. Adding another hormone drug does not automatically improve recovery or explain a poor response.
Notes

Solo versus combined PCT remains an argument. AnabolicMinds users disagreed about adding Clomid. One reported no side effects with solo Nolva; another associated headaches with the combination. A supplement representative described taking four weeks to feel normal. These accounts do not rank the options. Nolvadex Experiences (Community discussion · Accessed 2026-09-30)

+ clomiphene in classic PCT kits. [community]

Stacking adds uncertainty. Clomiphene combinations and comparisons with enclomiphene appear in the original record. It also preserves heavy-AI crash concerns. These are different drugs; adding one does not automatically improve recovery or explain a poor response.

Aromatase-inhibitor combinations: The original record includes concerns about feeling worse with heavy AI use. These accounts do not establish a cause, a corrective combination or improved recovery from adding another drug. [community]

Source context — Nolvadex Experiences: Uncontrolled PCT anecdotes; #14 identifies as a supplement representative. No verified lab units for #17's 350-to-1300 claim, so exact numbers omitted. #23's roughly six-day half-life refers ambiguously to Clomid in context and is not used for tamoxifen.

Watch for

Mood, fog and visionReports include depression, anxiety, sleepiness, poor concentration, brain fog and declining eyesight. One difficult mood account also involved stopping bupropion, so the cause cannot be assigned to tamoxifen alone.
Clot and eye risksThe label warns about thromboembolic events and eye problems. New vision trouble, leg swelling or unexplained breathlessness needs prompt medical assessment; oncology data do not establish a short-PCT event rate.
Pregnancy and medicinesThe label warns of fetal harm and increased anticoagulant effects with coumarin medicines such as warfarin. Other medication changes also complicate reported mood and recovery effects.
Notes

A smaller lump can come with a difficult month. The switch author described marked reduction alongside depression, anxiety, sleepiness and poor concentration, then better tolerance at 10 mg. They also stopped bupropion when switching from ineffective raloxifene, so the mood burden cannot be assigned to tamoxifen alone. My gyno experience: raloxifene did not work; tamoxifen switch and follow-up (Personal report · Accessed 2026-09-30)

A positive opening can have an adverse follow-up. The positive-experiences thread's author later reported stopping after two months because of brain fog and declining eyesight. A different commenter reported initial reduction followed by return after stopping. Neither story should become a simple cure testimonial. Positive Experiences on Tamoxifen or Raloxifene, including adverse follow-ups (Community discussion · Accessed 2026-09-30)

Clots and vision changes are drug risks, beyond forum worries. The label warns about thromboembolic events and eye problems; its boxed warning includes stroke and uterine malignancy in women using it for breast-cancer risk reduction. Those trial risks do not establish a short-PCT event rate. DailyMed Tamoxifen Citrate oral-tablet prescribing label (Official context · Accessed 2026-09-30)

Pregnancy and other medicines matter. The label warns of fetal harm and increased anticoagulant effects with coumarin medicines such as warfarin. Medication changes also complicate mood stories. New vision trouble, leg swelling or unexplained breathlessness warrants prompt medical assessment. DailyMed Tamoxifen Citrate oral-tablet prescribing label (Official context · Accessed 2026-09-30) · My gyno experience: raloxifene did not work; tamoxifen switch and follow-up (Personal report · Accessed 2026-09-30)

Source context — My gyno experience: raloxifene did not work; tamoxifen switch and follow-up: One account including follow-ups, not independent corroboration. Subjective tissue change, simultaneous antidepressant withdrawal; later follow-ups have relative timestamps only.

Source context — Positive Experiences on Tamoxifen or Raloxifene, including adverse follow-ups: Self-selected positive-story prompt; OP's later adverse reports are the same person. Subjective reduction and reported radiology not independently verified. Planned 40 mg increase at line 336 is not confirmed completed use. Hidden/deleted replies unavailable; commercial purchase suggestions excluded.

Source context — DailyMed Tamoxifen Citrate oral-tablet prescribing label: A-S Medication Solutions repackaged label, source NDC0591-2472. Medical breast-cancer contexts, not a PCT trial or a short-course male risk estimate. Rat mechanism text not promoted to human efficacy; no measured benefit duration.

Full notes

Tamoxifen, usually called Nolvadex or Nolva, is an oral selective estrogen-receptor modulator (SERM). Bodybuilding communities discuss it for breast-lump concerns and post-cycle therapy (PCT), meaning attempts to recover hormone function after suppressive drugs. Reports include smaller lumps, feeling unchanged and difficult mood or concentration problems; those outcomes are not interchangeable.

What Nolva does—and what people mean by gyno

  • A receptor drug, not an estrogen-production blocker. Tamoxifen changes estrogen signaling in particular tissues. An aromatase inhibitor (AI), such as anastrozole, reduces estrogen production. Calling both an estrogen blocker hides a practical difference: a breast-lump response does not show that circulating estrogen has fallen. Community Official context
  • Breast tissue and hormone recovery are different targets. Gyno means gynecomastia, growth of gland tissue around the nipple. Posters also discuss tenderness or puffiness without a confirmed diagnosis. PCT conversations instead focus on testosterone, libido and energy after steroid or SARM use. A nipple sensation alone cannot establish the cause. Community Personal report
  • Usually tablets, with quantities expressed in milligrams. The original discussions name 10 mg and 20 mg tablets, swallowed orally, with no reconstitution. Oncology treatment is a separate medical setting; its purpose and duration do not validate a bodybuilding course. Community Community

What people hope to gain

  • A smaller or less troubling breast lump. Several gynecomastia accounts describe visible or touchable reduction, sometimes incomplete. One commenter still had a lump after three weeks at 40 mg/day. The recurring interest in newer tissue is community discussion, not a guarantee that any lump will disappear. Reddit r/gynecomastia Community
  • Feeling normal again after a cycle. PCT users seek better energy, libido and hormone results. The original record also preserves the competing explanation that a bad week may be the post-cycle crash itself. Feeling better cannot establish durable hormone recovery. Community Personal report

Doses people discuss

These are reported oral amounts, not a personal regimen. Daily totals and course length need to be read together.

  • PCT: 20–40 mg/day in the original kit discussion; lower amounts also appear. A reopened Reddit post planned 20 mg daily for two weeks followed by 10 mg daily for two weeks. That was a proposed four-week course, not a completed success report. The older 20–40 mg band remains a separate community pattern. Community Reddit r/sarmssourcetalk
  • Gynecomastia: 10–20 mg/day, with distinct higher reports. One author reported 20 mg each night and later 10 mg daily. A different commenter described 40 mg/day for three weeks with partial reduction. These accounts do not establish a safe ceiling or show that more gives a better result. Community Personal report Reddit r/gynecomastia

Half-life: the circulating claims

  • About 3 days and 6 days are separate forum claims. An AnabolicMinds thread contains both numbers, without a primary measurement citation. Neither is a demonstrated clearance or drug-test window. The original record describes days-long presence; a better afternoon after a missed dose does not measure elimination. AnabolicMinds Community

Onset: when users notice something

  • Breast changes can be reported within days; PCT can feel unchanged initially. The medication-switch author described almost overnight reduction. Another PCT commenter felt no different on day six at 20 mg/day. These are different endpoints, and neither supplies a predictable onset for hormone recovery. Personal report Reddit r/sarmssourcetalk
  • Unwanted feelings can arrive early or later. A Bluelight author stopped an initial 20 mg/day attempt around day three, then described fatigue, restlessness, fog and severe sleep disruption around day 17 on a later attempt. Cannabis use and the preceding prohormone cycles complicate attribution. Personal report

Duration: what happens after stopping

  • No reliable single-dose benefit window. These accounts describe repeated use. One author reported no regrowth one month after stopping; another described breast tissue returning after a months-long course and less effect on retry. The positive thread's author reported brain fog continuing for a month after quitting. Personal report Reddit r/gynecomastia

Cycles and course length

  • Four-week PCT discussions are distinct from longer breast-lump accounts. The inspected PCT question proposed four weeks. The switch author later reported two months at 20 mg followed by one month at 10 mg. The original record frames PCT as weeks, not indefinite AI use. No supported repeat-cycle or time-off rule emerges here. Reddit r/sarmssourcetalk Personal report Community

Good to know

  • Clots and vision changes are drug risks, beyond forum worries. The label warns about thromboembolic events and eye problems; its boxed warning includes stroke and uterine malignancy in women using it for breast-cancer risk reduction. Those trial risks do not establish a short-PCT event rate. Official context Community
  • Pregnancy and other medicines matter. The label warns of fetal harm and increased anticoagulant effects with coumarin medicines such as warfarin. Medication changes also complicate mood stories. New vision trouble, leg swelling or unexplained breathlessness warrants prompt medical assessment. Official context Personal report
  • Stacking adds uncertainty. Clomiphene combinations and comparisons with enclomiphene appear in the original record. It also preserves heavy-AI crash concerns. These are different drugs; adding one does not automatically improve recovery or explain a poor response. Community

What actual accounts add

  • A smaller lump can come with a difficult month. The switch author described marked reduction alongside depression, anxiety, sleepiness and poor concentration, then better tolerance at 10 mg. They also stopped bupropion when switching from ineffective raloxifene, so the mood burden cannot be assigned to tamoxifen alone. Personal report
  • A positive opening can have an adverse follow-up. The positive-experiences thread's author later reported stopping after two months because of brain fog and declining eyesight. A different commenter reported initial reduction followed by return after stopping. Neither story should become a simple cure testimonial. Reddit r/gynecomastia
  • Hormone numbers do not always follow the expected story. After ostarine and four weeks of tamoxifen, one poster reported lower free testosterone and lower luteinizing hormone, a signal that stimulates testosterone production. Replies blamed fake product, but that was unverified. Supplements, test timing and changing hormone-binding proteins further limit interpretation. Personal report
  • Solo versus combined PCT remains an argument. AnabolicMinds users disagreed about adding Clomid. One reported no side effects with solo Nolva; another associated headaches with the combination. A supplement representative described taking four weeks to feel normal. These accounts do not rank the options. AnabolicMinds
  • No noticeable feeling is also a report. The day-six commenter took 20 mg before bed and noticed no change or side effects, despite another reply warning against night dosing. Clinic, forum and unverified-product experiences are different contexts; a seller name or favorable feeling does not verify contents. Reddit r/sarmssourcetalk Community

Formal context behind the timing numbers

  • Label values keep their medical origin. The oral-tablet label gives a terminal half-life of about 5–7 days for tamoxifen and approximately 14 days for N-desmethyl tamoxifen, a breakdown product. These are human pharmacology values, not user-measured benefit durations or PCT schedules. Official context

Open in the directory ↗All STUDresearch topics →